Press releases

DexTech: Inbjudan till öppen årsstämma samt kallelse

19 September, 2019

Torsdagen den 17 oktober 2019 kommer DexTech Medical AB (”DexTech”) att hålla årsstämma. I mån av plats är även icke aktieägare välkomna att delta utan rösträtt. Vid stämman kommer bland […]


Dextech Medical AB Annual report 180701 – 190630

19 September, 2019

Download annual report below. Dextech Annual Report 180701-190630


Report for DexTechs phase IIb-study for OsteoDex is ready

6 December, 2018

OsteoDex, the company ́s phase 2b-project for treatment of advanced prostate cancer, mCRPC, is reported. The study is titled “A randomised, double-blind, dose-finding, repeat dose Phase II multicentre study of […]


First result from DexTechs phase IIb-study on OsteoDex

4 October, 2018

OsteoDex, the company’s phase 2b-project for treatment of advanced prostate cancer, castration resistant prostate cancer (CRPC), is finished and the first results can be reported. The study has the title […]


Positive first results in DexTechs phase IIb-study for OsteoDex

9 February, 2017

The study has the title “A randomised, double-blind, dose finding, repeat dose Phase II multicentre study of ODX for the treatment of patients with castration resistant prostate cancer (CRPC) and […]


DexTech closes research agreement on glycosylation technology

2 November, 2015

Press release 2015-11-02 DexTech Medical AB, 556664-6203 DexTech closes research agreement on glycosylation technology DexTech announced today that Roche and DexTech have signed a research agreement with the aim to […]